Patient-Reported Outcome Measures in Dermatology: A Systematic Review
DOI:
https://doi.org/10.2340/00015555-3884Keywords:
quality of life, patient-reported outcome measures, measurement properties, dermatology-specific, burdenAbstract
By relying on data from existing patient-reported outcome measures of quality of life, the true impact of skin conditions on patients’ lives may be underestimated. This study systematically reviewed all dermatology-specific (used across skin conditions) patient-reported outcome measures and makes evidence-based recommendations for their use. The study protocol is registered on PROSPERO (CRD42018108829). PubMed, PsycInfo and CINAHL were searched from inception to 25 June 2018. The Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) criteria were used to assess the measurement properties and methodological quality of studies. A total of 12,925 abstracts were identified. Zero patient-reported outcome measures were assigned to category A (ready for use without further validation), 31 to category B (recommended for use, but only with further validation) and 5 to category C (not recommended for use). There is no gold-standard dermatology-specific patient-reported outcome measure that can be recommended or used without caution. A new measure that can comprehensively capture the impact of dermatological conditions on the patient’s life is needed.
Downloads
References
Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician 2001; 64: 1873–1878.
Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg 2013; 32: 101–109.
World Health Organization. Constitution of the World Health Organization. Geneva: World Health Organization; 1948.
Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient’s life cumulative? J Eur Acad Dermatol Venereol 2010; 24: 989–1004.
Bhatti ZU, Salek MS, Finlay AY. Major life changing decisions and cumulative life course impairment. J Eur Acad Dermatol Venereol 2011; 25: 245–246; author reply 246.
Terwee CB, Bot SDM, Boer MR de, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34–42.
DeVellis RF. Scale development: theory and applications. Fourth edition. Los Angeles: SAGE; 2017.
Souza ACd, Alexandre NMC, Guirardello EdB. Propriedades psicométricas na avaliação de instrumentos: avaliação da confiabilidade e da validade. Epidemiol Serv Saude 2017; 26: 649–659.
Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, Vet HCW de, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 2018; 27: 1147–1157.
Terwee CB, Jansma EP, Riphagen II, Vet HCW de. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res 2009; 18: 1115–1123.
Kitchen H, Cordingley L, Young H, Griffiths CEM, Bundy C. Patient-reported outcome measures in psoriasis: the good, the bad and the missing! Br J Dermatol 2015; 172: 1210–1221.
Mokkink LB, Vet HCW de, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res 2018; 27: 1171–1179.
Feeny DH, Eckstrom E, Whitlock EP, Perdue LA. A primer for systematic reviewers on the measurement of functional status and health-related quality of life in older adults. Agency for Healthcare Research and Quality (US), Rockville, MD, USA; 2013.
Augustin M, Zschocke I, Seidenglanz K, Lange S, Schiffler A, Amon U. Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin disease. Dermatol Psychosom 2000; 1: 12–17.
Schmid-Ott G, Burchard R, Niederauer HH, Lamprecht F, Künsebeck H-W. Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis. Hautarzt 2003; 54: 852–857.
Ofenloch RF, Diepgen TL, Weisshaar E, Elsner P, Apfelbacher CJ. Assessing health-related quality of life in hand eczema patients: how to overcome psychometric faults when using the dermatology life quality index. Acta Derm Venereol 2014; 94: 658–662.
Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol 2000; 39: 826–831.
He Z, Lu C, Chren M-M, Zhang Z, Li Y, Ni X, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes 2014; 12: 190.
Chernyshov PV. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity. G Ital Dermatol Venereol 2016; 151: 37–43.
Tiedra AG de, Mercadal J, Badía X, Mascaró JM, Lozano R. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology. Pharmacoeconomics 1998; 14: 405–422.
Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. Lebensqualität bei Haut- erkrankungen: Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis. Hautarzt 1999; 50: 715–722.
Hahn HB, Melfi CA, Chuang TY, Lewis CW, Gonin R, Hanna MP, et al. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. J Am Acad Dermatol 2001; 45: 44–48.
Korte J de, Mombers FMC, Sprangers MAG, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138: 1221–1227.
Shikiar R, Harding G, Leahy M, Lennox RD. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 2005; 3: 36.
Bronsard V, Paul C, Prey S, Puzenat E, Gourraud P-A, Aractingi S, et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24: 17–22.
Jones-Caballero M, Peñas PF, García-Díez A, Badía X, Chren MM. The Spanish version of Skindex-29. Int J Dermatol 2000; 39: 907–912.
Zachariae R, Zachariae C, Ibsen H, Mortensen JT, Wulf HC. Dermatology life Quality Index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000; 80: 272–276.
Jones-Caballero M, Peñas PF, García-Díez A, Chren MM, Badía X. [The Spanish version of Skindex-29. An instrument for measuring quality of life in patients with cutaneous diseases]Med Clin (Barc) 2002; 118: 5–9 (in Spanish).
Müller H, Brockow T, Franke A, Resch K-L, Calliess IT, Schmid-Ott G. Construct validity of the questionnaire on experience with skin complaints (Short Form). European Journal of Psychological Assessment 2007; 23: 176–184.
Madarasingha NP, Silva P de, Satgurunathan K. Validation study of Sinhala version of the dermatology life quality index (DLQI). Ceylon Med J 2011; 56: 18–22.
Milutinović JD, Krstić N, Janković SM. Translation and validation of the Serbian version of the Skindex-29 instrument for measuring impact of skin disease on quality of life. Acta Dermatovenerol Croat 2017; 25: 120–127.
Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003; 15: 532–549.
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942–949.
Chuh AAT. Validation of a Cantonese version of the Children’s Dermatology Life Quality Index. Pediatr Dermatol 2003; 20: 479–481.
Malakouti M, Brown GE, Leon A, Wang E, Naegeli AN, Edson-Heredia E, et al. The dermatologic intimacy scale: quantitatively measuring the impact of skin disease on intimacy. J Dermatolog Treat 2017; 28: 347–352.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006; 4: 71.
Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012; 132: 76–84.
Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004; 93: 142–146.
Ferraz LB, Almeida FA, Vasconcellos MR, Faccina AS, Ciconelli RM, Ferraz MB. The impact of lupus erythematosus cutaneous on the quality of life: the Brazilian-Portuguese version of DLQI. Qual Life Res 2006; 15: 565–570.
Liu Y, Li T, An J, Zeng W, Xiao S. Rasch analysis holds no brief for the use of the Dermatology Life Quality Index (DLQI) in Chinese neurodermatitis patients. Health Qual Life Outcomes 2016; 14: 17.
He Z, Lo Martire R, Lu C, Liu H, Ma L, Huang Y, et al. Rasch analysis of the dermatology life quality index reveals limited application to Chinese patients with skin disease. Acta Derm Venereol 2018; 98: 59–64.
Liu J-B, Yao M-Z, Si A-L, Xiong L-K, Zhou H. Life quality of Chinese patients with chronic urticaria as assessed by the Dermatology Life Quality Index. J Eur Acad Dermatol Venereol 2012; 26: 1252–1257.
He Z, Lu C, Basra MKA, Ou A, Yan Y, Li L. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2013; 27: 109–115.
Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 2005; 85: 409–413.
Mørk C, Wahl A, Moum T. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. Acta Derm Venereol 2002; 82: 347–351.
Balci DD, Inandi T. [Dermatology life quality index scores in lichen planus: comparison of psoriasis and healthy controls]. Arch Turkish Dermatol Venerol 2008; 42: 127 (in Turkish).
Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202–206.
Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41–50.
Anderson R, Rajagopalan R. Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial. Qual Life Res 1998; 7: 723–734.
Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561–571.
Cowdell F, Ersser SJ, Gradwell C, Thomas PW. The Person-Centered Dermatology Self-Care Index: a tool to measure education and support needs of patients with long-term skin conditions. Arch Dermatol 2012; 148: 1251–1255.
Mühleisen B, Büchi S, Schmidhauser S, Jenewein J, French LE, Hofbauer GFL. Pictorial Representation of Illness and Self Measure (PRISM): a novel visual instrument to measure quality of life in dermatological inpatients. Arch Dermatol 2009; 145: 774–780.
Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707–713.
Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433–1440.
Augustin M, Wenninger K, Amon U, Schroth MJ, Küster W, Chren M, et al. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004; 209: 14–20.
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001; 5: 105–110.
AlGhamdi KM, AlShammari SA. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol 2007; 46: 247–252.
Cárcano CBM, Oliveira CZ de, Paiva BSR, Paiva CE. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases. PLoS One 2018; 13: e0194492.
Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren M-M. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002; 29: 693–698.
El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi FZ, et al. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatolog Treat 2014; 25: 106–109.
Gurel MS, Yanik M, Simsek Z, Kati M, Karaman A. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol 2005; 44: 933–938.
Grob JJ, Auquier P, Martin S, Lançon C, Bonerandi JJ. Development and validation of a quality of life measurement for chronic skin disorders in french: VQ-Dermato. The RéseaudEpidémiolo gie en Dermatologie. Dermatology 1999; 199: 213–222.
Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014; 383: 166–175.
Gabes M, Tischer C, Apfelbacher C, Ebisawa M. Measurement properties of quality-of-life outcome measures for children and adults with eczema: an updated systematic review. Pediatr Allergy Immunol 2020; 31: 66–77.
Byrne BM, Campbell TL. Cross-cultural comparisons and the presumption of equivalent measurement and theoretical structure: a look beneath the surface. J Cross-Cultural Psychol 1999; 30: 555–574.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Philadelphia, Pa 1976) 2000; 25: 3186–3191.
Hawkins M, Cheng C, Elsworth GR, Osborne RH. Translation method is validity evidence for construct equivalence: analysis of secondary data routinely collected during translations of the Health Literacy Questionnaire (HLQ). BMC Med Res Methodol 2020; 20: 130.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010; 63: 737–745.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539–549.
Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy (Copenhagen) 2012; 67: 1111–1117.
Apfelbacher CJ, Heinl D, Prinsen CAC, Deckert S, Chalmers J, Ofenloch R, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: Protocol for a systematic review. Systemat Rev 2015; 4: 48.
Waters A, Sandhu D, Beattie P, Ezughah F, Lewis-Jones S. Severity stratification of Children’s Dermatology Life Quality Index (CDLQI) scores. Br J Dermatol 2010; 163: 121.
van Cranenburgh OD, Krol MW, Hendriks MCP, Rie MA de, Smets EMA, Korte J de, et al. Consumer Quality Index Chronic Skin Disease (CQI-CSD): a new instrument to measure quality of care from the patient’s perspective. Br J Dermatol 2015; 173: 1032–1040.
Herd RM, Tidman MJ, Ruta DA, Hunter JA. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1997; 136: 502–507.
Reilly MC, Lavin PT, Kahler KH, Pariser DM. Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis. J Am Acad Dermatol 2003; 48: 128–130.
Nijsten T, Sampogna F, Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009; 218: 151–154.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Rachael L. Pattinson, Nirohshah Trialonis-Suthakharan, Sunnia Gupta, Alasdair L. Henry, Jacqueline F. Lavallée, Marina Otten, Timothy Pickles, Nick Courtier, Jennifer Austin, Christine Janus, Matthias Augustin, Chris Bundy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
